ATE444739T1 - Polymerzusammensetzung sowie diese enthaltende darreichungsformen - Google Patents

Polymerzusammensetzung sowie diese enthaltende darreichungsformen

Info

Publication number
ATE444739T1
ATE444739T1 AT03714356T AT03714356T ATE444739T1 AT E444739 T1 ATE444739 T1 AT E444739T1 AT 03714356 T AT03714356 T AT 03714356T AT 03714356 T AT03714356 T AT 03714356T AT E444739 T1 ATE444739 T1 AT E444739T1
Authority
AT
Austria
Prior art keywords
dosage forms
polymer composition
forms containing
containing same
dosage form
Prior art date
Application number
AT03714356T
Other languages
English (en)
Inventor
Jen-Chi Chen
Frank Bunick
Harry Sowden
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2002/031117 external-priority patent/WO2003026629A2/en
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Priority claimed from PCT/US2003/008960 external-priority patent/WO2004028514A1/en
Application granted granted Critical
Publication of ATE444739T1 publication Critical patent/ATE444739T1/de

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03714356T 2002-09-28 2003-03-21 Polymerzusammensetzung sowie diese enthaltende darreichungsformen ATE444739T1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
PCT/US2002/031117 WO2003026629A2 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2002/031062 WO2003026626A2 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2002/031129 WO2003026630A1 (en) 2001-09-28 2002-09-28 Dosage forms having an inner core and outer shell with different shapes
PCT/US2002/031163 WO2003026627A1 (en) 2001-09-28 2002-09-28 Composite dosage forms
PCT/US2002/031024 WO2003026625A1 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2003/008960 WO2004028514A1 (en) 2002-09-28 2003-03-21 Polymer composition and dosage forms comprising the same

Publications (1)

Publication Number Publication Date
ATE444739T1 true ATE444739T1 (de) 2009-10-15

Family

ID=34271652

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03714356T ATE444739T1 (de) 2002-09-28 2003-03-21 Polymerzusammensetzung sowie diese enthaltende darreichungsformen

Country Status (8)

Country Link
JP (3) JP2006517514A (de)
CN (3) CN1684671A (de)
AT (1) ATE444739T1 (de)
AU (4) AU2003218359A1 (de)
BR (5) BR0314777A (de)
CA (3) CA2500313C (de)
DE (2) DE60329614D1 (de)
MX (1) MXPA05003283A (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2470463C (en) 2004-06-09 2012-09-18 Lornamead Brands, Inc. Tooth whitening products and methods of making the same
SA07280459B1 (ar) * 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
JP2011524891A (ja) * 2008-06-19 2011-09-08 ユニバーシティ・オブ・ジ・ウィトウォーターズランド・ヨハネスブルク 時間治療的医薬剤形
EP2550960A4 (de) * 2010-03-23 2013-08-28 Lintec Corp Feste zubereitung
EP3494974B1 (de) * 2011-07-08 2023-10-18 The University of North Carolina at Chapel Hill Metall-bisphosphonat-nanopartikel zur krebstherapie sowie bildgebung und zur behandlung von knochenerkrankungen
HK1203162A1 (en) * 2012-02-07 2015-10-23 麦克内尔-Ppc股份有限公司 Rapidly disintegrating coated tablets
TW201400146A (zh) * 2012-06-05 2014-01-01 Takeda Pharmaceutical 有核錠
BR112017005574A2 (pt) * 2014-09-19 2017-12-12 Procter & Gamble formas de dosagem de liberação pulsada de fenilefrina
US12161754B2 (en) 2017-12-20 2024-12-10 Purdue Pharma L.P. Abuse deterrent morphine sulfate dosage forms
JP7710850B2 (ja) * 2017-12-29 2025-07-22 ラクソン メディカル アーゲー 薬物送達システム
MX2024001390A (es) * 2021-07-30 2024-05-17 Evecxia Therapeutics Inc Formas de dosificacion gastrorretentivas de 5-hidroxitriptofano.
US12409163B2 (en) 2021-07-30 2025-09-09 Evecxia Therapeutics, Inc. Method of enhancing 5-hydroxytryptophan (5-HTP) exposure
CN115295864B (zh) * 2021-11-09 2023-08-11 深圳市德方创域新能源科技有限公司 正极补锂添加剂及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007470A1 (en) * 1992-09-30 1994-04-14 Pfizer Inc. Article containing a core and a coating having a non constant thickness
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
DE4431653C2 (de) * 1994-09-06 2000-01-20 Lohmann Therapie Syst Lts Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US6602521B1 (en) * 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
JPWO2001078681A1 (ja) * 2000-04-17 2004-01-08 山之内製薬株式会社 薬物動態学的な薬物相互作用を回避する薬物送達システム及びその方法
ES2261643T3 (es) * 2001-02-13 2006-11-16 Astrazeneca Ab Nueva formulacion de liberacion modificada.

Also Published As

Publication number Publication date
CN1700908A (zh) 2005-11-23
JP2006517182A (ja) 2006-07-20
CN1700907A (zh) 2005-11-23
JP2006517183A (ja) 2006-07-20
BR0314804A (pt) 2005-08-02
BR0314547A (pt) 2005-08-09
CA2500312A1 (en) 2004-04-08
MXPA05003283A (es) 2005-11-23
CA2500311A1 (en) 2004-04-08
CN1684671A (zh) 2005-10-19
BR0314777A (pt) 2005-07-26
CA2500313C (en) 2011-06-07
BR0314787A (pt) 2005-07-26
CA2500313A1 (en) 2004-04-08
AU2003218359A1 (en) 2004-04-19
JP2006517514A (ja) 2006-07-27
AU2003220466A1 (en) 2004-04-19
AU2003225944A1 (en) 2004-04-19
DE60335270D1 (de) 2011-01-20
AU2003220472A1 (en) 2004-04-19
BR0314781A (pt) 2005-07-26
DE60329614D1 (de) 2009-11-19

Similar Documents

Publication Publication Date Title
AU2003231126A1 (en) Chewable soft capsule
BRPI0500704A (pt) composições de tratamento pessoal reidratáveis
ATE444739T1 (de) Polymerzusammensetzung sowie diese enthaltende darreichungsformen
ATE288256T1 (de) Dermale zusammensetzungen
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
WO2003032953A1 (en) Granules containing acid-unstable chemical in large amount
BR0214279A (pt) Composições farmacêuticas em forma particulada
BR0206441A (pt) Composição de revestimento de pelìcula, revestimento de pelìcula cobrindo um núcleo farmacêutico, formulação farmacêutica de liberação modificada, e, processos para preparar uma composição de revestimento de pelìcula, um revestimento de pelìcula e uma formulação
AR011116A1 (es) Compuesto derivado de n-hidroxi-beta-sulfonil propionamida y composicion farmaceutica que lo contiene
ES2176502T3 (es) Derivados de hidroxilamina utiles para mejorar la pproduccion de chaperonas moleculares su su preparacion.
WO2004010941A3 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
WO2004028272A3 (en) Injectable growth promoting and anthelmintic composition
MXPA04000891A (es) Nuevos derivados de acido vinilcarboxilico y su uso como antidiabeticos.
BR0007589A (pt) Inibidores da proliferação de células
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
SE0401970D0 (sv) Novel compounds
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
ATE478662T1 (de) Arzneilösungen enthaltend modafinilverbindungen
FI20095606A7 (fi) Järjestelmä ja menetelmä alhaisen suspendoituneen kiintoainepitoisuuden omaavan liuoksen tuottamiseksi ja sellaisen liuoksen käyttö
ECSP055566A (es) Formulaciones de depósito de corta duración
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
PL376718A1 (pl) Nowe związki, ich wytwarzanie i stosowanie
DE60103619D1 (de) Pharmazeutische zubereitungen enthaltend alginate
IL165808A0 (en) Low molecular weight k5-n,o-oversulfated polysaccharide process for the preparation thereof and pharmaceutical compositions containing the same
SE0001916D0 (sv) Novel formulation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties